Assignee
DEVELCO PHARMA SCHWEIZ AG
CH·6 granted patents·4 pending applications·18 citations·filing 2014–2019
Top patents by PatentIndex Score
10 records- 0191US10335379B2Oral dosage forms of ketamineDEVELCO PHARMA SCHWEIZ AG·Filed 2015·Granted Jul 2, 2019·10 cites·15 claims
- 0287US11723883B2Hydroxynorketamine for the use in the treatment of depressionDEVELCO PHARMA SCHWEIZ AG·Filed 2018·Granted Aug 15, 2023·3 cites·11 claims
- 0386US11103467B2Method for treating depressionDEVELCO PHARMA SCHWEIZ AG·Filed 2019·Granted Aug 31, 2021·3 cites·16 claims
- 0474US9456986B2Naloxone mono preparation and multilayer tabletDEVELCO PHARMA SCHWEIZ AG·Filed 2014·Granted Oct 4, 2016·2 cites·18 claims
- 0551US10058547B2Naloxone single agent and multilayer tabletsDEVELCO PHARMA SCHWEIZ AG·Filed 2016·Granted Aug 28, 2018·0 cites·20 claims
- 0639US2021059944A1Novel dosage formDEVELCO PHARMA SCHWEIZ AG·Filed 2018·Application pending·0 cites
- 0736US10105360B2Method and composition for the treatment of opioid induced constipationDEVELCO PHARMA SCHWEIZ AG·Filed 2016·Granted Oct 23, 2018·0 cites·20 claims
- 0836US2016256452A1Composition Of Opioid Receptor Antagonists For Use In Treatment Of Constipation With Highly Increased Whole Gut Transit TimeDEVELCO PHARMA SCHWEIZ AG·Filed 2015·Application pending·0 cites
- 0932US2016256453A1Opioid receptor antagonist for use in treating patients with severe constipation induced by high opiate dosage regimenDEVELCO PHARMA SCHWEIZ AG·Filed 2015·Application pending·0 cites
- 1026US2016256451A1Dosage of naloxoneDEVELCO PHARMA SCHWEIZ AG·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when DEVELCO PHARMA SCHWEIZ AG files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →